¹¬¾±ÉÏƤÄÚÁöÑù²¡±ä,Cervical intraepithelial neoplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ¾úÐÔÒõµÀ²¡,Bacterial vaginosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²Ö×Áö,Ovarian neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÓýÆÚ,growth periodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢ÎÀÐDz»Îȶ¨,Microsatellite instabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬¾±Ö×Áö,Cervix neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±»Òý·ÖÎö,citation analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ç»Òº,peritoneal fluidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ó¹¬ÄÚĤÖ×Áö,Endometrial neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ó¹¬¾±ÉÏƤÄÚÁö±ä,cervical intraepithelial neoplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏõËáß俵ßò,Miconazole nitrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´àÐÔ×é°±ËáÈýÁªÌå,Fragile histidine triadÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÚλÄÚĤ,Eutopic endometriumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·¼Ï㻯øÒÖÖƼÁ,aromatase inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬Ç»ÄÚÈ˹¤ÊÚ¾«,Intrauterine inseminationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²´¢±¸¹¦ÄÜ,Ovarian reserveÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
RECK»ùÒò,RECK geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µâ»¯ÓÍ,LipiodolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²ÉÏƤ°©,epithelial ovarian cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÔ·´×ª,sex reversalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´×Ëá¼×ôÇÔÐͪ,medroxyprogesterone acetateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉúÖ³Ö§ÔÌå,Mycoplasma genitaliumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
͸Ã÷ϸ°û°©,Clear cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÑÎËá·ú¹ðÀûàº,Flunarizine HydrochlorideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²·´Ó¦ÐÔ,ovarian responseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±£ÊØÐÔÊÖÊõ,Conservative surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ÙÉöÉÏÏÙƤÖÊËØÊͷż¤ËØ,Corticotropin-releasing hormoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ºËÐļÒÍ¥,nuclear familyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Âѳ²·´Ó¦,Ovarian responseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Skp2µ°°×,Skp2 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅÅÂÑÂÊ,ovulation rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿ØÖÆÐÔ³¬´ÙÅÅÂÑ,controlled ovarian hyperstimulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
XȾɫÌåʧ»î,X chromosome inactivationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÌåÖؼõÇá,Weight lossÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄæÁ÷,countercurrentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬¾±Ï¸°ûѧ,Cervical cytologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ó¹¬ÄÚĤÔöÉúÖ¢,endometrial hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒìλÄÚĤ,Ectopic endometriumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HPV¸ÐȾ,HPV infectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²»Ã÷ÔÒò²»ÔÐ,Unexplained infertilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒõµÀ¾úȺ,vaginal floraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÑÅÝÆÚ,Follicular PhaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Åèµ×¹¦ÄÜÕÏ°,Pelvic floor dysfunctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×Ïõßò×¢ÉäÒº,Metronidazole injectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÈÃ×·Ò,clomipheneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Äò¼¤Ã¸ÐÍÏËÈÜøԼ¤»îÎïÊÜÌå,Urokinase-type plasminogen activator receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ÔÈ»ÖÜÆÚ,natural cycleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CYP1A1»ùÒò,CYP1A1 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CD44v6,CD 44 v 6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
À䶳ÅßÌ¥,frozen embryoÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Æ¢ÀÒ°±Ëἤø,spleen tyrosine kinaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
p15µ°°×,p15 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐÂÉú¶ù½á¾Ö,Neonatal outcomeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´«µÝ²»Æ½ºâ¼ìÑé,Transmission disequilibrium testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
AKTµ°°×,AKT proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»ÆÌåÖ§³Ö,luteal supportÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´×Ëá»·±ûÔÐͪ,cyproterone acetateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
³É±¾Ð§Ó÷ÖÎö,Cost-utility analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¿¹ÃçÀչܼ¤ËØ,Anti-mullerian hormoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒõµÀ×éÖ¯,Vaginal tissueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢±Õ¾,Primary amenorrheaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒõµÀÄîÖé¾ú²¡,vaginal candidiasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬¾±Õ³Òº,cervical mucusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÄêÇḾŮ,Young womenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ËÁ£Ã¸»ùÒò,telomerase geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Leepµ¶,Leep knifeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ó«¹âÔλÔÓ½»(FISH),fluorescence in situ hybridization (FISH)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
GSTM1»ùÒò,GSTM1 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÏÙÉÏƤϸ°û,Glandular epithelial cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢Á£Ìå»·Ñõ»¯ÎïË®½âø,Microsomal epoxide hydrolaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸´·¢ÐÔÍâÒõÒõµÀÄîÖé¾ú²¡,recurrent vulvovaginal candidiasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ó¹¬ÄÚĤ¼äÖÊϸ°û,endometrial stromal cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÊȸõËØA,chromogranin AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö±³¦Ö×Áö/Õï¶Ï,rectal neoplasms/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍâÒõÉÏƤÄÚ·ÇÁöÑù²¡±ä,nonneoplastic epithelial disorders of vulvaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÓÕµ¼ÅÅÂÑ,Ovulation inductionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÙ´²·ÖÀà,Clinical classificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¾ø¾ºóÒõµÀ³öѪ,Postmenopausal bleedingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÅèÇ»¼²²¡,Pelvic diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È˹¤Êܾ«,Artificial inseminationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼×Ïõßò˨,metronidazole suppositoriesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
È˦·ÀÓùËØ-2,human ¦Â-defensin-2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²¡Àý±¨µÀ,case reportÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÃÀ±¦´´ÃæËÙÓúÌù,MEBO Dressing for Accelerating Wound HealingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô¾Á¿,Menstrual blood volumeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬¾±ð¤Òº,cervical mucusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÕ³¸½·Ö×Ó-1,Intercellular adhesion molecule-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÎ³æÒõµÀÑ×,trichomonal vaginitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×óȲŵÔÐͪ¹¬ÄÚÊÍ·Åϵͳ,Levonorgestrel-releasing intrauterine systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÂÔÌå¸ÐȾ,chlamydia infectionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÖÏ®ÐÔѪ¹Üð¤ÒºÁö,aggressive angiomyxomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ú¿µßò½ºÄÒ,Fluconazole capsuleÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÍâÒõÁÛ״ϸ°û°©,Vulvar squamous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µòÍö;¾¶,Apoptosis pathwayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñ¡ÔñÐÔÊäÂѹÜÔìÓ°Êõ,Selective salpingographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ë¿°±Ëá/ËÕ°±Ëἤø,serine/threonine kinaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Å®ÐÔÐÔ¹¦ÄÜÕÏ°,female sexual dysfunctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PercollÌݶÈÀëÐÄ·¨,Percoll gradient centrifugationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ç°Í¥´óÏÙÄÒÖ×,Bartholin cystÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹¬¾±ÉÏƤÄÚÁö±ä(CIN),Cervical intraepithelial neoplasia(CIN)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
|